Crescent Biopharma Inc
F:C68
Crescent Biopharma Inc
F:C68
Price:
14.6
EUR
-0.68%
Market Cap:
€202.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Crescent Biopharma Inc
F:C68
|
US |
|
Lumentum Holdings Inc
NASDAQ:LITE
|
US |
|
Brunswick Corp
NYSE:BC
|
US |
|
Nippon Yusen KK
TSE:9101
|
JP |
|
Qube Holdings Ltd
ASX:QUB
|
AU |
Wall St Price Targets
C68 Price Targets Summary
Crescent Biopharma Inc
Crescent Biopharma Inc
Wall Street analysts forecast C68 stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for C68 is 11.86 EUR with a low forecast of 9.12 EUR and a high forecast of 15.08 EUR.
Lowest Forecast
Price Target
9.12
EUR
38% Downside
Average Forecast
Price Target
11.86
EUR
19% Downside
Highest Forecast
Price Target
15.08
EUR
3% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C68's stock price target?
Price Target
11.86
EUR
11.86
EUR
According to Wall Street analysts, the average 1-year price target for C68 is 11.86 EUR with a low forecast of 9.12 EUR and a high forecast of 15.08 EUR.
What is the Revenue forecast for Crescent Biopharma Inc?
Projected CAGR
81%
81%
Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 8 years is 81%.
